Leveraging home-monitoring vision tech for urgent tele-ophthalmology appointments during COVID and beyond

在新冠疫情期间及之后利用家庭视力监测技术进行紧急远程眼科预约

基本信息

  • 批准号:
    69729
  • 负责人:
  • 金额:
    $ 3.24万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Feasibility Studies
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    已结题

项目摘要

Due to COVID-19, all routine face-to-face eye care appointments have been suspended (both in hospital ophthalmology and in community opticians). Since routine appointments comprise approximately 80% of all eye care appointments, and in 2019 eye units became the busiest hospital outpatient speciality, this is a major disruption for the NHS as a whole, and the 6 million patients in the UK who live with eye disease.The eye chart is a fundamental aspect of assessing eye health, and, founded by eye specialists, OKKO are a certified software medical device company that creates technology to provide this on smartphones (using pictures, not letters, via a simple, accessible video game interface that has been co-developed by children as young as 3 years old and adults up to 85 years!). Our patent-pending and CE-marked technology to date has been concentrating on chronic disease in adults. However, the cancellation of NHS eye appointments means that there's now huge demand for the product in paediatrics and also in urgent care, so we have been redeveloping our core tech for this purposes:1. Home-monitoring children's vision for those undergoing at-home patching treatment for lazy eye (amblyopia)2. For one-off urgent use during tele-ophthalmology video consultationsOur technical work is nearly complete for our iOS product on Apple devices, however we urgently need to create an Android version for Samsung and Huawei phones, in order to meet NHS demand in an equitable way. In addition, we must urgently create an automated 'on-boarding' procedure for easy registration online. This means quickly doubling the size of our tech team to build the necessary stable and scalable platform.Last year NHS England had 7.86 million eye care appointments, just 3.7% which were seen by tele-health means (usually a telephone call to check on the patient's symptoms post-surgery).Given COVID-19, a full roll-out of tele-health is now essential, but the limiting factor is the ability to accurately measure sight in the home.OKKO's patent-pending technology specifically meets this need, and it's integration could ramp up the ability to deliver proper eye care during COVID and mitigate the effects the growing backlog of cancelled appointments and the continued impact of social distancing (ie doctors with asthma/diabetes who are shielding could instead be running clinics from their home). With the correct product acceleration, our technology could be used to raise the tele-health in ophthalmology to 50% by late 2020 and utilise the eye specialists who are shielding.
由于COVID-19,所有常规面对面眼科护理预约均已暂停(包括医院眼科和社区配镜师)。由于常规预约约占所有眼科护理预约的80%,2019年眼科单位成为最繁忙的医院门诊专科,这对整个NHS以及英国600万患有眼疾的患者来说是一个重大干扰。视力表是评估眼睛健康的基本方面,由眼科专家创立,OKKO是一家经过认证的软件医疗设备公司,该公司创造了在智能手机上提供这一功能的技术(使用图片,而不是字母,通过一个简单,可访问的视频游戏界面,由3岁以下的儿童和85岁以下的成年人共同开发!)。迄今为止,我们正在申请专利和获得CE认证的技术一直专注于成人慢性疾病。然而,NHS眼科预约的取消意味着现在儿科和紧急护理对该产品的需求巨大,因此我们一直在为此重新开发我们的核心技术:1.为正在接受弱视家庭修补治疗的儿童进行家庭视力监测2.在远程眼科视频咨询期间一次性紧急使用我们的iOS产品在Apple设备上的技术工作已接近完成,但我们迫切需要为三星和华为手机创建Android版本,以便以公平的方式满足NHS需求。此外,我们必须紧急创建一个自动化的“入职”程序,以方便在线注册。这意味着我们的技术团队的规模迅速扩大一倍,以建立必要的稳定和可扩展的平台。去年,NHS英格兰有786万次眼科护理预约,只有3.7%是通过远程医疗手段看到的(通常是打电话检查病人手术后的症状)。考虑到COVID-19,全面推广远程医疗现在至关重要,但限制因素是在家中精确测量视力的能力。OKKO正在申请专利的技术专门满足了这一需求,它的整合可以提高在COVID期间提供适当眼科护理的能力,并减轻日益积压的取消预约和社交距离的持续影响(即患有哮喘/糖尿病的医生谁是屏蔽可以代替运行诊所从他们的家)。通过正确的产品加速,我们的技术可以在2020年底之前将眼科的远程医疗提高到50%,并利用正在屏蔽的眼科专家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 3.24万
  • 项目类别:
    Studentship

相似海外基金

Leveraging Wearables to Transform Patient Recovery after Tibial Fracture Surgery
利用可穿戴设备改变胫骨骨折手术后患者的康复
  • 批准号:
    10658494
  • 财政年份:
    2023
  • 资助金额:
    $ 3.24万
  • 项目类别:
Leveraging remote blood pressure monitoring and interpretable machine learning to improve clinical workflows for hypertensive disorders of pregnancy
利用远程血压监测和可解释的机器学习来改善妊娠期高血压疾病的临床工作流程
  • 批准号:
    10822625
  • 财政年份:
    2023
  • 资助金额:
    $ 3.24万
  • 项目类别:
Leveraging electronic health record tools to reduce health disparities for patients with uncontrolled hypertension
利用电子健康记录工具减少未受控制的高血压患者的健康差异
  • 批准号:
    10542667
  • 财政年份:
    2020
  • 资助金额:
    $ 3.24万
  • 项目类别:
Leveraging electronic health record tools to reduce health disparities for patients with uncontrolled hypertension
利用电子健康记录工具减少未受控制的高血压患者的健康差异
  • 批准号:
    10319624
  • 财政年份:
    2020
  • 资助金额:
    $ 3.24万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10439510
  • 财政年份:
    2020
  • 资助金额:
    $ 3.24万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10216356
  • 财政年份:
    2020
  • 资助金额:
    $ 3.24万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10041734
  • 财政年份:
    2020
  • 资助金额:
    $ 3.24万
  • 项目类别:
Implementation Science to Improve Cardiovascular Health: Leveraging EHR Systems to Advance Care of Resistant Hypertension
改善心血管健康的实施科学:利用 EHR 系统推进难治性高血压的护理
  • 批准号:
    10653690
  • 财政年份:
    2020
  • 资助金额:
    $ 3.24万
  • 项目类别:
Project 2: Leveraging Ongoing Home Visitation Programs to Address Obesity Disparities among Underserved, Low-Income Mothers and Children
项目 2:利用持续的家访计划解决服务不足、低收入母亲和儿童之间的肥胖差异
  • 批准号:
    10161624
  • 财政年份:
    2003
  • 资助金额:
    $ 3.24万
  • 项目类别:
Project 2: Leveraging Ongoing Home Visitation Programs to Address Obesity Disparities among Underserved, Low-Income Mothers and Children
项目 2:利用持续的家访计划解决服务不足、低收入母亲和儿童之间的肥胖差异
  • 批准号:
    9913392
  • 财政年份:
  • 资助金额:
    $ 3.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了